Published in Nat Cell Biol on February 20, 2011
Telomeric DNA damage is irreparable and causes persistent DNA-damage-response activation. Nat Cell Biol (2012) 3.03
Cellular senescence and its effector programs. Genes Dev (2014) 2.37
Chromatin replication and epigenome maintenance. Nat Rev Mol Cell Biol (2012) 2.25
Accumulation of the inner nuclear envelope protein Sun1 is pathogenic in progeric and dystrophic laminopathies. Cell (2012) 2.18
Cellular senescence and tumor suppressor gene p16. Int J Cancer (2011) 2.14
TGF-beta signaling engages an ATM-CHK2-p53-independent RAS-induced senescence and prevents malignant transformation in human mammary epithelial cells. Proc Natl Acad Sci U S A (2011) 1.94
Oncogene-induced telomere dysfunction enforces cellular senescence in human cancer precursor lesions. EMBO J (2012) 1.71
UHRF1 overexpression drives DNA hypomethylation and hepatocellular carcinoma. Cancer Cell (2014) 1.50
Crosstalk between chromatin state and DNA damage response in cellular senescence and cancer. Nat Rev Cancer (2012) 1.45
Oncogenic RAS regulates BRIP1 expression to induce dissociation of BRCA1 from chromatin, inhibit DNA repair, and promote senescence. Dev Cell (2011) 1.43
Lysosome-mediated processing of chromatin in senescence. J Cell Biol (2013) 1.38
Dietary phytochemicals, HDAC inhibition, and DNA damage/repair defects in cancer cells. Clin Epigenetics (2011) 1.31
A kinase shRNA screen links LATS2 and the pRB tumor suppressor. Genes Dev (2011) 1.30
Global reorganization of the nuclear landscape in senescent cells. Cell Rep (2015) 1.28
Two distinct modes for propagation of histone PTMs across the cell cycle. Genes Dev (2015) 1.22
Assessing cell and organ senescence biomarkers. Circ Res (2012) 1.17
Tumor-specific activation of the C-JUN/MELK pathway regulates glioma stem cell growth in a p53-dependent manner. Stem Cells (2013) 1.17
Autophagy-dependent senescence in response to DNA damage and chronic apoptotic stress. Autophagy (2012) 1.17
Histone deacetylase regulation of ATM-mediated DNA damage signaling. Mol Cancer Ther (2013) 1.15
Higher-order unfolding of satellite heterochromatin is a consistent and early event in cell senescence. J Cell Biol (2013) 1.13
Depleting the methyltransferase Suv39h1 improves DNA repair and extends lifespan in a progeria mouse model. Nat Commun (2013) 1.12
Activation of Bmp2-Smad1 signal and its regulation by coordinated alteration of H3K27 trimethylation in Ras-induced senescence. PLoS Genet (2011) 1.10
The great unravelling: chromatin as a modulator of the aging process. Trends Biochem Sci (2012) 1.04
Diverse lamin-dependent mechanisms interact to control chromatin dynamics. Focus on laminopathies. Nucleus (2014) 0.96
BRG1 is required for formation of senescence-associated heterochromatin foci induced by oncogenic RAS or BRCA1 loss. Mol Cell Biol (2013) 0.95
Global heterochromatin loss: a unifying theory of aging? Epigenetics (2012) 0.95
Homeodomain transcription factor and tumor suppressor Prep1 is required to maintain genomic stability. Proc Natl Acad Sci U S A (2011) 0.95
Chromatin dynamics in DNA double-strand break repair. Biochim Biophys Acta (2012) 0.93
Analysis of human syndromes with disordered chromatin reveals the impact of heterochromatin on the efficacy of ATM-dependent G2/M checkpoint arrest. Mol Cell Biol (2011) 0.93
High-order chromatin structure and the epigenome in SAHFs. Nucleus (2012) 0.93
Detection of senescence-associated heterochromatin foci (SAHF). Methods Mol Biol (2013) 0.90
HIRA orchestrates a dynamic chromatin landscape in senescence and is required for suppression of neoplasia. Genes Dev (2014) 0.89
Markers of cellular senescence. Telomere shortening as a marker of cellular senescence. Aging (Albany NY) (2016) 0.88
DNA damage, chromatin, and transcription: the trinity of aging. Curr Opin Cell Biol (2012) 0.88
Dynamics of histone H3.3 deposition in proliferating and senescent cells reveals a DAXX-dependent targeting to PML-NBs important for pericentromeric heterochromatin organization. Cell Cycle (2013) 0.88
Senescence at a glance. J Cell Sci (2013) 0.88
Mutation of the LXCXE binding cleft of pRb facilitates transformation by ras in vitro but does not promote tumorigenesis in vivo. PLoS One (2013) 0.87
Stable cellular senescence is associated with persistent DDR activation. PLoS One (2014) 0.87
Carbon-ion beam irradiation kills X-ray-resistant p53-null cancer cells by inducing mitotic catastrophe. PLoS One (2014) 0.87
ATM activation in hypoxia - causes and consequences. Mol Cell Oncol (2014) 0.86
ATM regulates insulin-like growth factor 1-secretory clusterin (IGF-1-sCLU) expression that protects cells against senescence. PLoS One (2014) 0.85
Never-ageing cellular senescence. Eur J Cancer (2011) 0.85
Progerin reduces LAP2α-telomere association in Hutchinson-Gilford progeria. Elife (2015) 0.85
Deacetylation of H4-K16Ac and heterochromatin assembly in senescence. Epigenetics Chromatin (2012) 0.84
Mitogen-induced B-cell proliferation activates Chk2-dependent G1/S cell cycle arrest. PLoS One (2014) 0.83
Lessons from senescence: Chromatin maintenance in non-proliferating cells. Biochim Biophys Acta (2011) 0.82
Histone deacetylases inhibition by SAHA/Vorinostat normalizes the glioma microenvironment via xCT equilibration. Sci Rep (2014) 0.82
Chromatin remodeling, DNA damage repair and aging. Curr Genomics (2012) 0.82
Epigenetic rejuvenation. Genes Cells (2012) 0.82
Reorganization of chromosome architecture in replicative cellular senescence. Sci Adv (2016) 0.81
Chromatin maintenance and dynamics in senescence: a spotlight on SAHF formation and the epigenome of senescent cells. Chromosoma (2014) 0.81
Inhibition of histone deacetylases enhances DNA damage repair in SCNT embryos. Cell Cycle (2014) 0.80
Controlled DNA double-strand break induction in mice reveals post-damage transcriptome stability. Nucleic Acids Res (2015) 0.80
Dasatinib induces DNA damage and activates DNA repair pathways leading to senescence in non-small cell lung cancer cell lines with kinase-inactivating BRAF mutations. Oncotarget (2016) 0.80
Identification of 5-Iodotubercidin as a genotoxic drug with anti-cancer potential. PLoS One (2013) 0.80
Chromatin relaxation-mediated induction of p19INK4d increases the ability of cells to repair damaged DNA. PLoS One (2013) 0.80
A damage limitation exercise. Nat Cell Biol (2011) 0.80
'Relax and Repair' to restrain aging. Aging (Albany NY) (2011) 0.80
A high-content screening assay for small-molecule modulators of oncogene-induced senescence. J Biomol Screen (2013) 0.79
Inhibition of vascular endothelial growth factor A and hypoxia-inducible factor 1α maximizes the effects of radiation in sarcoma mouse models through destruction of tumor vasculature. Int J Radiat Oncol Biol Phys (2014) 0.79
MRX protects fork integrity at protein-DNA barriers, and its absence causes checkpoint activation dependent on chromatin context. Nucleic Acids Res (2013) 0.79
Regulation of oncogene-induced cell cycle exit and senescence by chromatin modifiers. Cancer Biol Ther (2012) 0.78
Alterations of Nuclear Architecture and Epigenetic Signatures during African Swine Fever Virus Infection. Viruses (2015) 0.78
Replication Stress: A Lifetime of Epigenetic Change. Genes (Basel) (2015) 0.78
17AAG Treatment Accelerates Doxorubicin Induced Cellular Senescence: Hsp90 Interferes with Enforced Senescence of Tumor Cells. Drug Target Insights (2012) 0.77
Stress induced premature senescence: a new culprit in ovarian tumorigenesis? Indian J Med Res (2014) 0.77
Immortalised breast epithelia survive prolonged DNA replication stress and return to cycle from a senescent-like state. Cell Death Dis (2014) 0.77
Lycopene modulates cellular proliferation, glycolysis and hepatic ultrastructure during hepatocellular carcinoma. World J Hepatol (2016) 0.77
Linking replication stress with heterochromatin formation. Chromosoma (2015) 0.76
Vitamin D/vitamin D receptor axis regulates DNA repair during oncogene-induced senescence. Oncogene (2016) 0.76
Acute dyskerin depletion triggers cellular senescence and renders osteosarcoma cells resistant to genotoxic stress-induced apoptosis. Biochem Biophys Res Commun (2014) 0.76
Metabolic alterations accompanying oncogene-induced senescence. Mol Cell Oncol (2014) 0.76
Mapping H4K20me3 onto the chromatin landscape of senescent cells indicates a function in control of cell senescence and tumor suppression through preservation of genetic and epigenetic stability. Genome Biol (2016) 0.76
Old cells, new tricks: chromatin structure in senescence. Mamm Genome (2016) 0.76
RAS, cellular senescence and transformation: the BRCA1 DNA repair pathway at the crossroads. Small GTPases (2012) 0.76
DNA damage, tumor mutational load and their impact on immune responses against cancer. Ann Transl Med (2016) 0.76
Subversion of host genome integrity by bacterial pathogens. Nat Rev Mol Cell Biol (2016) 0.75
ZNF224, Krüppel like zinc finger protein, induces cell growth and apoptosis-resistance by down-regulation of p21 and p53 via miR-663a. Oncotarget (2016) 0.75
DNA damage in the oligodendrocyte lineage and its role in brain aging. Mech Ageing Dev (2016) 0.75
Tuberatolide B Suppresses Cancer Progression by Promoting ROS-Mediated Inhibition of STAT3 Signaling. Mar Drugs (2017) 0.75
WSB1 overcomes oncogene-induced senescence by targeting ATM for degradation. Cell Res (2016) 0.75
Peritoneal carcinomatosis of colorectal cancer is characterized by structural and functional reorganization of the tumor microenvironment inducing senescence and proliferation arrest in cancer cells. Oncoimmunology (2016) 0.75
Lentivirus-mediated Knockdown of HDAC1 Uncovers Its Role in Esophageal Cancer Metastasis and Chemosensitivity. J Cancer (2016) 0.75
Derepression of hTERT gene expression promotes escape from oncogene-induced cellular senescence. Proc Natl Acad Sci U S A (2016) 0.75
Mitotic catastrophe is a putative mechanism underlying the weak correlation between sensitivity to carbon ions and cisplatin. Sci Rep (2017) 0.75
The chromatin associated Phf12 protein maintains nucleolar integrity and prevents premature cellular senescence. Mol Cell Biol (2016) 0.75
Physiological and Pathological Aging Affects Chromatin Dynamics, Structure and Function at the Nuclear Edge. Front Genet (2016) 0.75
Epigenetics in Brain Tumors: HDACs Take Center Stage. Curr Neuropharmacol (2016) 0.75
Cellular senescence in osteoarthritis pathology. Aging Cell (2017) 0.75
Impact of senescence-associated secretory phenotype and its potential as a therapeutic target for senescence-associated diseases. Cancer Sci (2017) 0.75
Unfolding the story of chromatin organization in senescent cells. Nucleus (2015) 0.75
Epigenetic Regulation of Cellular Senescence and Aging. Front Genet (2017) 0.75
Chromatin Dynamics in Genome Stability: Roles in Suppressing Endogenous DNA Damage and Facilitating DNA Repair. Int J Mol Sci (2017) 0.75
Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell (1997) 29.13
Methylation of histone H3 lysine 9 creates a binding site for HP1 proteins. Nature (2001) 19.67
Regulation of chromatin structure by site-specific histone H3 methyltransferases. Nature (2000) 18.26
ONCOMINE: a cancer microarray database and integrated data-mining platform. Neoplasia (2004) 17.08
BRAFE600-associated senescence-like cell cycle arrest of human naevi. Nature (2005) 16.87
Cellular senescence: when bad things happen to good cells. Nat Rev Mol Cell Biol (2007) 16.55
Creation of human tumour cells with defined genetic elements. Nature (1999) 16.47
Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis. Nature (2005) 15.83
A DNA damage checkpoint response in telomere-initiated senescence. Nature (2003) 12.55
Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints. Nature (2006) 11.76
An oncogene-induced DNA damage model for cancer development. Science (2008) 11.60
Rb-mediated heterochromatin formation and silencing of E2F target genes during cellular senescence. Cell (2003) 11.40
Oncogene-induced senescence is a DNA damage response triggered by DNA hyper-replication. Nature (2006) 11.18
Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer. Nat Rev Cancer (2006) 10.73
Tumour biology: senescence in premalignant tumours. Nature (2005) 10.15
Oncogene-induced senescence as an initial barrier in lymphoma development. Nature (2005) 9.16
Cellular senescence in cancer and aging. Cell (2007) 9.04
ATR and ATRIP: partners in checkpoint signaling. Science (2001) 7.58
Lamin A-dependent nuclear defects in human aging. Science (2006) 6.71
ATM signaling facilitates repair of DNA double-strand breaks associated with heterochromatin. Mol Cell (2008) 6.60
Telomere shortening triggers senescence of human cells through a pathway involving ATM, p53, and p21(CIP1), but not p16(INK4a). Mol Cell (2004) 6.48
Senescence in tumours: evidence from mice and humans. Nat Rev Cancer (2010) 6.34
Cellular senescence in aging primates. Science (2006) 6.24
Reversal of human cellular senescence: roles of the p53 and p16 pathways. EMBO J (2003) 5.61
Chromatin relaxation in response to DNA double-strand breaks is modulated by a novel ATM- and KAP-1 dependent pathway. Nat Cell Biol (2006) 5.34
The DNA damage signaling pathway is a critical mediator of oncogene-induced senescence. Genes Dev (2007) 4.91
Formation of MacroH2A-containing senescence-associated heterochromatin foci and senescence driven by ASF1a and HIRA. Dev Cell (2005) 4.83
A novel role for high-mobility group a proteins in cellular senescence and heterochromatin formation. Cell (2006) 4.74
DNA damage triggers a prolonged p53-dependent G1 arrest and long-term induction of Cip1 in normal human fibroblasts. Genes Dev (1994) 4.64
Living on a break: cellular senescence as a DNA-damage response. Nat Rev Cancer (2008) 4.63
Senescence induced by altered telomere state, not telomere loss. Science (2002) 4.17
Control of the replicative life span of human fibroblasts by p16 and the polycomb protein Bmi-1. Mol Cell Biol (2003) 4.05
Identification of a specific inhibitor of the histone methyltransferase SU(VAR)3-9. Nat Chem Biol (2005) 3.49
53BP1-dependent robust localized KAP-1 phosphorylation is essential for heterochromatic DNA double-strand break repair. Nat Cell Biol (2010) 2.88
The heterochromatin protein 1 prevents telomere fusions in Drosophila. Mol Cell (1998) 2.88
Healing and hurting: molecular mechanisms, functions, and pathologies of cellular senescence. Mol Cell (2009) 2.58
Molecular dissection of formation of senescence-associated heterochromatin foci. Mol Cell Biol (2007) 2.56
Heterochromatin is refractory to gamma-H2AX modification in yeast and mammals. J Cell Biol (2007) 2.55
Global chromatin compaction limits the strength of the DNA damage response. J Cell Biol (2007) 2.40
The influence of heterochromatin on DNA double strand break repair: Getting the strong, silent type to relax. DNA Repair (Amst) (2010) 2.24
ATR signaling can drive cells into senescence in the absence of DNA breaks. Genes Dev (2008) 2.17
Dynamic assembly of chromatin complexes during cellular senescence: implications for the growth arrest of human melanocytic nevi. Aging Cell (2007) 2.07
Senescence, apoptosis and therapy--cutting the lifelines of cancer. Nat Rev Cancer (2003) 1.91
Ino80 chromatin remodeling complex promotes recovery of stalled replication forks. Curr Biol (2008) 1.89
Definition of pRB- and p53-dependent and -independent steps in HIRA/ASF1a-mediated formation of senescence-associated heterochromatin foci. Mol Cell Biol (2007) 1.62
Deregulated E2F activity induces hyperplasia and senescence-like features in the mouse pituitary gland. Mol Cell Biol (2005) 1.61
Cellular senescence and chromatin structure. Chromosoma (2007) 1.26
Chromatin assembly factors Asf1 and CAF-1 have overlapping roles in deactivating the DNA damage checkpoint when DNA repair is complete. Proc Natl Acad Sci U S A (2009) 1.25
Mobilization and recruitment of HP1: a bimodal response to DNA breakage. Cell Cycle (2009) 1.23
Breaking news: high-speed race ends in arrest--how oncogenes induce senescence. Trends Cell Biol (2007) 1.22
Heterochromatin protein 1alpha: a hallmark of cell proliferation relevant to clinical oncology. EMBO Mol Med (2009) 1.12
Remodeling chromatin for senescence. Aging Cell (2007) 1.06
Oncogenes and senescence: breaking down in the fast lane. Genes Dev (2007) 1.05
Interaction between HP1alpha and replication proteins in mammalian cells. Exp Cell Res (2006) 1.01
Association of the SUV39H1 histone methyltransferase with the DNA methyltransferase 1 at mRNA expression level in primary colorectal cancer. Int J Cancer (2007) 0.98
Modulation of the E2F1-driven cancer cell fate by the DNA damage response machinery and potential novel E2F1 targets in osteosarcomas. Am J Pathol (2009) 0.97
HDAC inhibitor-mediated radiosensitization in human carcinoma cells: a general phenomenon? J Radiat Res (2010) 0.95
A genetic screen identifies topoisomerase 1 as a regulator of senescence. Cancer Res (2009) 0.86
Epigenetic therapies in haematological malignancies: searching for true targets. Eur J Cancer (2009) 0.85
Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy (2012) 20.08
A lentiviral RNAi library for human and mouse genes applied to an arrayed viral high-content screen. Cell (2006) 18.81
Initial genome sequencing and analysis of multiple myeloma. Nature (2011) 17.28
Malignant astrocytic glioma: genetics, biology, and paths to treatment. Genes Dev (2007) 17.20
Cellular senescence: when bad things happen to good cells. Nat Rev Mol Cell Biol (2007) 16.55
COT drives resistance to RAF inhibition through MAP kinase pathway reactivation. Nature (2010) 14.62
BET bromodomain inhibition as a therapeutic strategy to target c-Myc. Cell (2011) 14.34
Transformation from committed progenitor to leukaemia stem cell initiated by MLL-AF9. Nature (2006) 11.90
Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints. Nature (2006) 11.76
Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1. Nature (2009) 11.46
Oncogene-induced senescence is a DNA damage response triggered by DNA hyper-replication. Nature (2006) 11.18
Dissecting therapeutic resistance to RAF inhibition in melanoma by tumor genomic profiling. J Clin Oncol (2011) 8.37
Lentivirus-delivered stable gene silencing by RNAi in primary cells. RNA (2003) 8.07
Chemokine signaling via the CXCR2 receptor reinforces senescence. Cell (2008) 7.65
Integrative genomic approaches identify IKBKE as a breast cancer oncogene. Cell (2007) 7.60
SOX2 is an amplified lineage-survival oncogene in lung and esophageal squamous cell carcinomas. Nat Genet (2009) 7.48
Highly parallel identification of essential genes in cancer cells. Proc Natl Acad Sci U S A (2008) 7.45
The Polycomb group proteins bind throughout the INK4A-ARF locus and are disassociated in senescent cells. Genes Dev (2007) 6.77
The tumor suppressor p53 regulates polarity of self-renewing divisions in mammary stem cells. Cell (2009) 6.64
A signalling pathway controlling c-Myc degradation that impacts oncogenic transformation of human cells. Nat Cell Biol (2004) 6.61
Synthetic lethal interaction between oncogenic KRAS dependency and STK33 suppression in human cancer cells. Cell (2009) 6.55
Human SIR2 deacetylates p53 and antagonizes PML/p53-induced cellular senescence. EMBO J (2002) 6.37
CDK8 is a colorectal cancer oncogene that regulates beta-catenin activity. Nature (2008) 6.24
Methyltransferase recruitment and DNA hypermethylation of target promoters by an oncogenic transcription factor. Science (2002) 6.05
Oncogenic transformation by inhibitor-sensitive and -resistant EGFR mutants. PLoS Med (2005) 6.04
Minimizing the risk of reporting false positives in large-scale RNAi screens. Nat Methods (2006) 5.96
Profiling critical cancer gene mutations in clinical tumor samples. PLoS One (2009) 5.63
High-throughput detection of actionable genomic alterations in clinical tumor samples by targeted, massively parallel sequencing. Cancer Discov (2011) 5.30
A public genome-scale lentiviral expression library of human ORFs. Nat Methods (2011) 4.98
Recurrent BRAF mutations in Langerhans cell histiocytosis. Blood (2010) 4.96
Feedback circuit among INK4 tumor suppressors constrains human glioblastoma development. Cancer Cell (2008) 4.71
AKT-independent signaling downstream of oncogenic PIK3CA mutations in human cancer. Cancer Cell (2009) 4.71
Comparative oncogenomics identifies NEDD9 as a melanoma metastasis gene. Cell (2006) 4.68
Gene expression signature-based chemical genomic prediction identifies a novel class of HSP90 pathway modulators. Cancer Cell (2006) 4.52
Regulation of in situ to invasive breast carcinoma transition. Cancer Cell (2008) 4.46
The JAK2/STAT3 signaling pathway is required for growth of CD44⁺CD24⁻ stem cell-like breast cancer cells in human tumors. J Clin Invest (2011) 4.41
Electron transfer between cytochrome c and p66Shc generates reactive oxygen species that trigger mitochondrial apoptosis. Cell (2005) 4.36
The SIRT1 deacetylase suppresses intestinal tumorigenesis and colon cancer growth. PLoS One (2008) 4.32
Systematic investigation of genetic vulnerabilities across cancer cell lines reveals lineage-specific dependencies in ovarian cancer. Proc Natl Acad Sci U S A (2011) 4.15
Genome-scale loss-of-function screening with a lentiviral RNAi library. Nat Methods (2006) 4.12
Activation of Notch-1 signaling maintains the neoplastic phenotype in human Ras-transformed cells. Nat Med (2002) 4.04
Protein kinase C beta and prolyl isomerase 1 regulate mitochondrial effects of the life-span determinant p66Shc. Science (2007) 3.92
Immortalization and transformation of primary human airway epithelial cells by gene transfer. Oncogene (2002) 3.80
Chemosensitivity linked to p73 function. Cancer Cell (2003) 3.63
Emerging insights into the molecular and cellular basis of glioblastoma. Genes Dev (2012) 3.44
Cell-cycle restriction limits DNA damage and maintains self-renewal of leukaemia stem cells. Nature (2009) 3.37
Human mammary epithelial cell transformation through the activation of phosphatidylinositol 3-kinase. Cancer Cell (2003) 3.33
β-Catenin-driven cancers require a YAP1 transcriptional complex for survival and tumorigenesis. Cell (2012) 3.33
Telomerase maintains telomere structure in normal human cells. Cell (2003) 3.29
Identification of specific PP2A complexes involved in human cell transformation. Cancer Cell (2004) 3.29
BLUEPRINT to decode the epigenetic signature written in blood. Nat Biotechnol (2012) 3.24
Identification of genotype-selective antitumor agents using synthetic lethal chemical screening in engineered human tumor cells. Cancer Cell (2003) 3.23
Genomic sequencing of meningiomas identifies oncogenic SMO and AKT1 mutations. Nat Genet (2013) 3.19
Role of the polycomb repressive complex 2 in acute promyelocytic leukemia. Cancer Cell (2007) 3.16
An oncogene-tumor suppressor cascade drives metastatic prostate cancer by coordinately activating Ras and nuclear factor-kappaB. Nat Med (2010) 3.09
Functional analysis of receptor tyrosine kinase mutations in lung cancer identifies oncogenic extracellular domain mutations of ERBB2. Proc Natl Acad Sci U S A (2012) 3.06
An RNA-dependent RNA polymerase formed by TERT and the RMRP RNA. Nature (2009) 3.04
Telomeric DNA damage is irreparable and causes persistent DNA-damage-response activation. Nat Cell Biol (2012) 3.03
A genetically defined model for human ovarian cancer. Cancer Res (2004) 3.02
Making sense of cancer genomic data. Genes Dev (2011) 3.01
An activated ErbB3/NRG1 autocrine loop supports in vivo proliferation in ovarian cancer cells. Cancer Cell (2010) 2.85
Telomerase contributes to tumorigenesis by a telomere length-independent mechanism. Proc Natl Acad Sci U S A (2002) 2.82
Inhibitors of histone deacetylases induce tumor-selective apoptosis through activation of the death receptor pathway. Nat Med (2004) 2.71
PLAGL2 regulates Wnt signaling to impede differentiation in neural stem cells and gliomas. Cancer Cell (2010) 2.68
A two-stage, p16(INK4A)- and p53-dependent keratinocyte senescence mechanism that limits replicative potential independent of telomere status. Mol Cell Biol (2002) 2.66
Loss of ATRX, genome instability, and an altered DNA damage response are hallmarks of the alternative lengthening of telomeres pathway. PLoS Genet (2012) 2.63
A p53-p66Shc signalling pathway controls intracellular redox status, levels of oxidation-damaged DNA and oxidative stress-induced apoptosis. Oncogene (2002) 2.55
Fatty acid synthase: a metabolic enzyme and candidate oncogene in prostate cancer. J Natl Cancer Inst (2009) 2.53
Multiple pathways regulated by the tumor suppressor PP2A in transformation. Trends Mol Med (2008) 2.52
Integrated analysis of molecular and clinical prognostic factors in stage II/III colon cancer. J Natl Cancer Inst (2012) 2.49
A prostatic intraepithelial neoplasia-dependent p27 Kip1 checkpoint induces senescence and inhibits cell proliferation and cancer progression. Cancer Cell (2008) 2.48
The bromodomain protein Brd4 insulates chromatin from DNA damage signalling. Nature (2013) 2.46
Proteomic and genetic approaches identify Syk as an AML target. Cancer Cell (2009) 2.39
Androgen-induced differentiation and tumorigenicity of human prostate epithelial cells. Cancer Res (2004) 2.32
Identification of a DNA nonhomologous end-joining complex in bacteria. Science (2002) 2.27
Site-specific DICER and DROSHA RNA products control the DNA-damage response. Nature (2012) 2.20
Role for the PP2A/B56delta phosphatase in regulating 14-3-3 release from Cdc25 to control mitosis. Cell (2006) 2.15
Control of cyclin D1 and breast tumorigenesis by the EglN2 prolyl hydroxylase. Cancer Cell (2009) 2.15
Roots and stems: stem cells in cancer. Nat Med (2006) 2.13
The tumor suppressor PP2A Abeta regulates the RalA GTPase. Cell (2007) 2.10
Involvement of PP2A in viral and cellular transformation. Oncogene (2005) 2.07
The telomerase reverse transcriptase regulates chromatin state and DNA damage responses. Proc Natl Acad Sci U S A (2005) 2.01
Phosphorylation of the tumor suppressor CYLD by the breast cancer oncogene IKKepsilon promotes cell transformation. Mol Cell (2009) 2.00
Effect of sildenafil on haemodynamic response to exercise and exercise capacity in Fontan patients. Eur Heart J (2008) 1.99
Wilms tumor 1 (WT1) regulates KRAS-driven oncogenesis and senescence in mouse and human models. J Clin Invest (2010) 1.98
Cancer vulnerabilities unveiled by genomic loss. Cell (2012) 1.95
Hypomethylation of retrotransposable elements correlates with genomic instability in non-small cell lung cancer. Int J Cancer (2009) 1.94
An oncogenic role for ETV1 in melanoma. Cancer Res (2010) 1.94
Involvement of the histone deacetylase SIRT1 in chicken ovalbumin upstream promoter transcription factor (COUP-TF)-interacting protein 2-mediated transcriptional repression. J Biol Chem (2003) 1.93
Genomic alterations link Rho family of GTPases to the highly invasive phenotype of pancreas cancer. Proc Natl Acad Sci U S A (2008) 1.92
Pattern of retinoblastoma pathway inactivation dictates response to CDK4/6 inhibition in GBM. Proc Natl Acad Sci U S A (2010) 1.91
ATARiS: computational quantification of gene suppression phenotypes from multisample RNAi screens. Genome Res (2012) 1.86
Transformation of human and murine fibroblasts without viral oncoproteins. Mol Cell Biol (2005) 1.81
Erosion of the telomeric single-strand overhang at replicative senescence. Nat Genet (2003) 1.78
PML NBs associate with the hMre11 complex and p53 at sites of irradiation induced DNA damage. Oncogene (2002) 1.77
Surgical management of double outlet right ventricle with intact ventricular septum. Ann Thorac Surg (2003) 1.72
Oncogene-induced telomere dysfunction enforces cellular senescence in human cancer precursor lesions. EMBO J (2012) 1.71